Clinical Trial Update: TELSYS - TELmisartan Effectiveness in Isolated SYStolic Hypertension Versus Systolic/Diastolic Hypertension Patients Aged 55 or Older

View source ↗

Summary

The TELSYS trial evaluating telmisartan in isolated systolic hypertension versus systolic/diastolic hypertension in adults 55 and older has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Isolated Systolic Hypertension

Drugs mentioned

• Telmisartan (Telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Status: COMPLETED